BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Biotech Bay

  Alto Neuroscience to Present at the Oppenheimer 33rd Annual Healthcare Conference

  Alto Neuroscience today announced that founder and chief executive officer, Amit Etkin, M.D., Ph.D., will present at the Oppenheimer 33rd Annual Healthcare Conference taking place virtually.

  March 6, 2023

   · 

  1 min read
• Drug Development

  RG6501 (OpRegen®) Phase 1/2a Results to Be Featured at 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Presentation by Eyal Banin, M.D., Ph.D.

  Lineage Cell Therapeutics, Inc. today announced that results from imaging analyses of structural changes in addition to visual data from a Phase 1/2a clinical study of RG6501.

  March 6, 2023

   · 

  4 min read
• Biotech Beach

  ChromaDex to Participate at the 35th Annual ROTH Capital Partners Conference on March 13, 2023

  ChromaDex Corp. (NASDAQ:CDXC) (“the Company”) a global bioscience company dedicated to healthy aging, today announced that senior management will participate at the 35th annual ROTH Capital Partners Conference at the Ritz-Carlton in Dana Point, CA.

  March 6, 2023

   · 

  3 min read
• Business

  Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2022 Financial Results on March 21, 2023

  Hyperfine, Inc. announced that it will report financial results for the fourth quarter and full year 2022 on Tuesday, March 21, 2023.

  March 6, 2023

   · 

  2 min read